PARTNER PROFILE

Institute for Health Data Science, Lanzhou University | China

Accelerating the translation of evidence to practice in China.

 

Overview

Learn more about about the Institute for Health Data Science team and how PEERSS supports their work.

Team members

Meet the experts that make up the PEERSS team in China.

Research

See the most recent research and resources from the Institute for Health Data Science.

Connect

Connect directly with the China team.

Partner team overview

Lanzhou University Institute of Health Data Science logo

The Institute of Health Data Science at Lanzhou University was established in January 2020 and aims to accelerate the translation of evidence to practice in China.

Under the PEERSS partnership, the Institute of Health Data Science has worked to make evidence more accessible and decisions more collaborative in China.

With PEERSS funding and support, the Institute has worked to:

Disseminate social and health-related Chinese COVID-19 literature and share the Chinese experience with other countries and organizations.

Establish a COVID-19 Chinese evidence sharing platform which is accessible to researchers and decision-makers around the world.

Provide Chinese evidence and relevant policies to support other PEERSS partner teams.

Gain the trust of key decision-makers and stakeholders in the evidence-informed policymaking space.

Moving forward, partners from China will continue to promote evidence-informed policymaking by:

Conducting methodological research on the evidence-based social science ecosystem.

Holding stakeholder dialogues and workshops with key actors to promote international collaboration.

Conducting a rapid synthesis and developing a policy brief that is informed by that synthesis.

Meet the experts from China.

Role
Team Lead
Areas of Expertise
Clinical practice guidelines; Reporting guidelines
Country
China
Role
Researcher
Areas of Expertise
Statistics; Public management
Country
China
Role
Coordinator, Researcher
Areas of Expertise
Evidence-based social science
Country
China
Role
Researcher
Areas of Expertise
Evidence brief for policy; Health policy
Country
China
Role
Researcher
Areas of Expertise
Health Policy, Evidence-informed policymaking; Health system guidance
Country
China

Publications, policy briefs and other resources from the Institute for Health Data Science

PEERSS Site Icon

Issue brief on pathophysiology and clinical manifestation for COVID-19 Pandemic

Language

English

Year Published

2020

Type of Resource

Issue Brief

Issue brief on Treatment for COVID-19 Pandemic

The world is now desperate to find ways to slow the spread of the novel coronavirus and to find effective treatments. To date, there are more than 200 clinical trials of COVID-19 treatments or vaccines that are either ongoing or recruiting patients. New ones are being added every day. The drugs being tested range from repurposed flu treatments to failed ebola drugs, to malaria treatments that were first developed decades ago.
Language

English

Year Published

2020

Type of Resource

Issue Brief

Avoidable Waste in the Production and Reporting of Evidence

The causes and degree of research waste occur in four sequential stages. But from our point of view, another very important factor we should consider is the affordability of access to published research articles. How much research is wasted because those who might benefit from it cannot afford to see its results?
Language

English

Year Published

2009

Type of Resource

EIDM Guide

Consort 2021

The reporting quality of randomised controlled trials is still being perfected. However, reporting guidelines such as CONSORT and PRISMA are not well disseminated and implemented in China.
Language

English

Year Published

2010

Type of Resource

Guidelines

Managing conflicts of interest in practice guidelines panels

Practice guidelines are an important innovation in patient care. According to the 2011 Institute of Medicine (IOM) definition, practice guidelines are “statements that include recommendations, intended to optimize patient care, that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options.”1 In the United States, guideline programs began in the early 1980s. As guidelines have been used for decisions about insurance coverage and standards for measuring quality of care, they have become increasingly influential, and conflict of interest (COI) in developing guidelines has become an important concern.
Language

English

Year Published

2017

Type of Resource

Guidelines

Clinical practice guidelines in China

Yaolong Chen and coworkers analyse the situation and challenges for clinical practice guidelines in China and provide recommendations for their development and implementation.
Language

English

Year Published

2018

Type of Resource

Guidelines

Have a question about the research from China?

Use the contact form below to submit a message to the PEERSS team or reach out via email.

china@peerss.org

PEERSS PARTNERS

Explore the World of Evidence

tooltip text
\
tooltip text

Brazil

\
tooltip text

Cameroon

\
tooltip text

China

\
tooltip text

Ethiopia

\
tooltip text

Nigeria

\
tooltip text

Burkina Faso

\
tooltip text

Trinidad and Tobago

\
tooltip text

United Kingdom

\
tooltip text

Chile

\
tooltip text

Colombia

\
tooltip text

Lebanon

\
tooltip text

South Africa

\
tooltip text

Uganda

en_USEnglish